Publicly funded vaccines

Last updated: September 14, 2023

This information is for health professionals.

On this page: Flu vaccine claims (2023-2024) COVID-19 vaccine Publicly funded vaccine PINs  

PharmaCare pays a fee when an authorized pharmacist, and in some cases non-pharmacist, administers a publicly funded vaccine to eligible B.C. residents. The fee for most publicly funded vaccines is $12.10. The fee for the COVID-19 vaccine is $18.00.

Key details:

  • Enter COVID-19 and publicly funded influenza vaccinations in ImmsBC only
    • Enter all other vaccinations in PharmaNet
  • Vaccine administrations must be entered on the day of the vaccination
  • Record the lot number for every vaccine administered, in case of rare events such as a vaccine recall or an adverse event following immunization (AEFI). For PharmaNet entries, record the lot number the SIG field

Refer to the BCCDC’s B.C. Immunization Manual for criteria, immunization schedule and other important information.

Non-pharmacist vaccine administration 

PharmaCare allows pharmacies to claim the  administration fee if a contracted nurse administers an influenza or COVID-19 vaccine.

Any nurse administering an influenza or COVID-19 vaccine in a B.C. pharmacy must be:

  • Licensed by the B.C. College of Nurses and Midwives (BCCNM); i.e., they must be an active registrant of that college (LPNs, NPs, RNs, and RPNs), OR
  • Permitted under the November 4, 2022, Provincial Health Officer order, as student nurses or retired nurses, with supervision as per the PHO order

Flu vaccines can be administered by a pharmacy technician or pharmacy student, as authorized under the November 4, 2022, PHObut must be supervised by a college registrant authorized under a health profession regulation.

How to claim publicly funded vaccines

Refer to COVID-19 claims and flu vaccine claims for procedures for those vaccines.

If administered to eligible patients for publicly funded vaccines:

  • Use the appropriate PIN in PharmaNet
  • Enter the quantity as the fluid volume of the vaccine (e.g. 0.5 mL)
  • In SIG field, enter lot number and injection arm (RIGHT or LEFT) or “bilateral” for nasal spray, separated by an underscore _
  • Do not enter a drug cost or fee
  • Do not enter an intervention code

Patients who are not eligible:

  • Dispense the vaccine ordered from your private supplier
  • Enter the product’s DIN in PharmaNet
  • In SIG field, enter lot number and injection arm (RIGHT or LEFT) or “bilateral” for nasal spray, separated by an underscore _
  • Charge the patient directly

Flu vaccine claims (2023-2024)

Once the annual campaign has officially begun (Sep 1 - June 1), pharmacies may submit claims for flu vaccinations.

Publicly funded flu vaccines

  • Record in ImmsBC
  • Use the vaccine DIN 
  • Records will be shared with PharmaNet, allowing PharmaCare to process the claim
  • Note that in ImmsBC, a drug use evaluation (DUE) does not automatically occur

The publicly funded flu vaccines for the 2023 – 2024 season are:

Private vaccine claims

Private supply vaccinations are eligible for PharmaCare’s drug administration fee of $11.41.

Three publicly funded flu vaccines are also available for private supply.

  • If product is both private and public supply:
  • If product is uniquely private, enter the DIN in PharmaNet

COVID-19 vaccines

Enter COVID-19 vaccinations in ImmsBC only. Records will be shared with PharmaNet, allowing PharmaCare to process the claim.

Vaccine product group Brand Vaccine product PIN
COVID-19 Vaxzevria
Manufacturer: AstraZeneca
COVID-19 vaccine (ChAdOx1-S [recombinant]) 66127320
Applies to both 8-dose and 10-dose vials
COVID-19 Comirnaty®
Manufacturer: Pfizer-BioNTech
COVID-19 vaccine (tozinameran) 66127303
Applies to both 6-dose and 10-dose vials
Manufacturer: Moderna
COVID-19 vaccine (elasomeran) 66127304

Publicly funded vaccine PINs

Publicly funded vaccine PINs
Vaccine product group Vaccine product PIN
Haemophilus b conjugate Act-HIB® 66128205
Haemophilus influenzae type b conjugate Hiberix® 66128170
Hepatitis A Avaxim 66124760
Avaxim Pediatric 66124831
Havrix® 1440 66124768
Havrix® Junior 720 66124769
Vaqta® Adult 66124794
Vaqta® Pediatric 66124795
Hepatitis B Engerix® B 66124764
Engerix® B Pediatric 66128130
Recombivax HB® 66124789
Recombivax HB® Adult Dialysis 66124790
Recombivax HB® Pediatric 66124791
Human papillomavirus (2 strains) Cervarix™ 66127902
Human papillomavirus (9 strains) Gardasil® 9 66128117
Measles, mumps, rubella MMR-II 66124781
Priorix 66124834
Measles, mumps, rubella, and varicella virus Proquad® 66128068
Priorix-Tetra 66128069
Meningococcal group B Bexsero 66128075
Meningococcal C conjugate Meningitec 66124832
Menjugate® 66128114
Neis Vac-C® 66124782
Pneumococcal conjugate 13-valent Prevnar 13 66128070
Pneumococcal 23-valent Pneumovax® 23 66124785
IPV (polio for travel indications) Imovax® Polio 66124773
Quadrivalent meningococcal conjugate Menveo 66128071
Menactra 66128072
Nimenrix® 66128152
Rabies RabAvert® 66124788
Smallpox and Monkeypox Imvamune®  66128369
Tetanus, diphtheria Td Adsorbed 66124793
Tetanus, diphtheria, acellular pertussis Adacel® 66124758
Boostrix® 66127901
Tetanus, diphtheria, acellular pertussis, polio adsorbed Quadracel® 66124787
Adacel® Polio 66128131
Boostrix®-Polio 66128094
Tetanus, diphtheria, acellular pertussis, polio, hepatitis B, haemophilus influenzae type b adsorbed Infanrix hexa® 66124776
Tetanus, diphtheria, IPV (polio for travel indications) Td Polio Adsorbed 66124792
Varicella Varilrix® 66124796
Varivax® III 66124797


Section 8.10 – Pharmacist administration of drugs and vaccines